Parsonage–Turner syndrome of the brachial plexus secondary to COVID‐19 vaccine: A case report | Zendy

Mejri Islam | Zendy; Ben Hmida Lenda | Zendy; Bedoui Ines | Zendy; Znegui Tasnim | Zendy; Kacem Maroua | Zendy; Moatemri Zied | Zendy; Derbali Hajer | Zendy; Jammeli Samia | Zendy; Fekih Mrissa Nejiba | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Parsonage–Turner syndrome of the brachial plexus secondary to COVID‐19 vaccine: A case report

Author(s) -

Mejri Islam,

Ben Hmida Lenda,

Bedoui Ines,

Znegui Tasnim,

Kacem Maroua,

Moatemri Zied,

Derbali Hajer,

Jammeli Samia,

Fekih Mrissa Nejiba

Publication year - 2022

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.6483

Subject(s) - medicine , etiology , covid-19 , brachial plexus , surgery , pediatrics , anesthesia , disease , infectious disease (medical specialty)

Parsonage–Turner syndrome (PTS) is a peripheral inflammatory neuropathy of unknown etiology. We present a rare case of a 50‐year‐old male patient with PTS post‐COVID‐19 BNT162b2 mRNA vaccine. Symptoms occurred 15 days after the second dose. He was treated with corticosteroids, analgesics, and physical rehabilitation with a partial recovery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research